In reply [2]

JAMA

Volumn 298, Issue 8, 2007, Pages 859-860

  Beohar, Nirat ^a   Davidson, Charles J ^a   Kip, Kevin E ^b   Vlachos, Helen A ^b   Williams, David O ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGINA PECTORIS; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; HAZARD RATIO; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

EID: 34548157155     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.298.8.859-b     Document Type: Letter

References (4)

1. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516.
2. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II). Circulation. 2007;115(9):1082-1089.
3. Serruys PW, Ong AT, Herwerden LA, et al. Five year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. J Am Coll Cardiol. 2005;46(4):575-581.
4. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: a meta-analysis of randomized controlled trials. BMJ. 2000;321(7253):73-77.